Oligonucleotide Synthesis Market- Global Analysis and Forecast

Oligonucleotide Synthesis Market – Global Market Size, Strategic Growth Drivers, Risk Assessment Framework, Regulatory Landscape Review, Competitive Intensity Mapping & Long-Term Industry Outlook to 2034

14.87%

CAGR (2026-2034)

8.70 USD Bn.

Forecast Market Size

318

Report Pages

141

Market Tables

Overview

Oligonucleotide Synthesis Market was valued at US$ 8.70 Bn in 2025 and is expected to reach 30.32 Bn by 2034, at a CAGR of 14.87% during the forecast period.

Oligonucleotide Synthesis Market Dynamics:

The oligonucleotide synthesis market has found major development in the recent years and is anticipated to grow tremendously during the forecast period. Oligonucleotides are short sections of nucleic acids that are united utilizing enzyme chemistry and genetic engineering. These are utilized for diagnostics, therapeutic, and in addition industrial and academic. Oligonucleotides synthesis takes place technologically to give services to different end-users or independently by means of DNA synthesizers for self-utilization.

The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region.

Oligonucleotide Synthesis Market Growth Outlook

To know about the Research Methodology :- Request Free Sample Report

The global market for oligonucleotide synthesis may also face a restriction in its growth due to the lack of available resources. The oligonucleotide synthesis market is expected to witness limitations in the availability of funding for research in academic laboratories, which may hamper market revenue growth. Along with this, there are also a restricted number of market players existing in some regions and a shortage of skilled personnel. These factors may hinder the growth of research activities.

Oligonucleotide Synthesis Market Segment Analysis:

The synthesized oligos segment held the largest share of the market in 2025 and is expected to grow at the highest CAGR during the forecast period. Growth in this segment is attributed to the growing applications of synthesized oligos in therapeutics, research, and diagnostics.

The biotechnology & Pharmaceutical Companies segment is expected to lead the market for oligonucleotide synthesis. Pharmaceutical industries and biotechnology companies are focused on looking for alternative approaches for disease treatment. As a result, these companies are making major use of oligonucleotides, as it offers an effective mode of action for the treatment of several indications at comparatively lower development costs.

Oligonucleotide Synthesis Market Regional Insights:

North America is expected to hold the largest market size for the oligonucleotide synthesis globally. The Asian market size is expected to grow at the highest CAGR, mainly owing to the rising accessibility of synthesized oligos, along with a rise in R&D funding and activities in the region. Japan and China are considered the most attractive markets with respect to growth opportunities present in these countries. Additionally, changing economic scenario, along with high investments in healthcare, life science-related research programs, and genetics, has encouraged global players to enter the Asia Pacific market, thus helping its growth.

Recent developments in the market for oligonucleotide synthesis: In March 2018, Danaher Corporation publicized that they have acquired Integrated DNA Technologies. The main of the acquisition is to increase their business in the genomics market and with IDT to develop critical diagnostic tests and potential life-saving therapies. They want to provide consumers highest standards of quality, service, and technical expertise.

In February 2021, Integrated DNA Technologies announced that they have acquired GeneWorks Pty Ltd. The main goal of the acquisition is to expand its business in the Asia- Pacific regions. They want to provide high-quality products and services to the scientist around the world.

The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data, and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Oligonucleotide Synthesis Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence.

Oligonucleotide Synthesis Market Recent Development

Date	Company	Development	Impact
14 January 2025	Thermo Fisher Scientific	Thermo Fisher Scientific launched its high-throughput DynaSpin oligonucleotide purification platform to accelerate large-scale commercial RNA synthesis.	The system significantly improves purification yields and downstream processing efficiency for therapeutic nucleic acid production.
28 February 2025	Agilent Technologies	Agilent Technologies announced the completion of its state-of-the-art commercial-scale cGMP manufacturing facility expansion for therapeutic oligonucleotides in Frederick, Colorado.	This development doubles the company's manufacturing capacity to meet surging global market demand for siRNA and antisense drug programs.
15 May 2025	Twist Bioscience	Twist Bioscience launched its new enzymatic oligonucleotide synthesis chemistry suite, enabling long-strand DNA assembly with ultra-low error rates.	The innovation enhances synthesis scale and speed while eliminating toxic chemical waste associated with traditional phosphoramidite methods.
18 September 2025	Merck KGaA	Merck KGaA entered into a strategic collaboration with Telesis Bio to co-develop automated enzymatic RNA oligonucleotide synthesis instruments for decentralized clinical researchers.	The alliance accelerates custom oligo delivery timelines from weeks to hours, streamlining personalized mRNA and targeted therapy R&D.
12 November 2025	Nitto Denko Avecia	Nitto Denko Avecia expanded its contract development and manufacturing organization (CDMO) capabilities by opening a specialized oligo conjugation center in Milford, Massachusetts.	The facility strengthens support for advanced lipid and peptide oligonucleotide delivery systems for rare disease therapies.

Oligonucleotide Synthesis Industry Ecosystem

Oligonucleotide Synthesis Market, Key Highlights:

1. Global Oligonucleotide Synthesis Market analysis and forecast, in terms of value.

2. Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Oligonucleotide Synthesis Market

3. Global Oligonucleotide Synthesis Market segmentation on the basis of Product Type, Application, end-user, and region (country-wise) has been provided.

4. Global Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study.

5. Global Oligonucleotide Synthesis Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.

6. Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.

7. Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Market are also profiled.

Oligonucleotide Synthesis Market Report Scope : Inquire before buying

Oligonucleotide Synthesis Market
Report Coverage	Details
Base Year:	2025	Forecast Period:	2026-2034
Historical Data:	2020 to 2025	Market Size in 2025:	US $ 8.70 Bn.
Forecast Period 2026 to 2034 CAGR:	14.87%	Market Size in 2034:	US $ 30.32 Bn.
Segments Covered:	by Product Type	Reagents & Consumables Equipment Synthesized oligonucleotides DNA oligonucleotides RNA oligonucleotides Others
	by Application	Research Polymerase Chain Reaction (PCR) Next Generation Sequencing Therapeutics Antisense Oligonucleotides Nucleic Acid Aptamers Diagnostics Others
	by End User	Hospital Pharmaceutical & Biotechnology Companies Diagnostic Laboratories CROs & CMOs Academic Research Institutes

Oligonucleotide Synthesis Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Oligonucleotide Synthesis Market, Key Players:

The Oligonucleotide Synthesis market encompasses the global commercial activity, revenues, and supply chain for producing custom and bulk synthetic DNA and RNA molecules, automated synthesizers, chemical reagents, and related manufacturing services used in genetic research, molecular diagnostics, and therapeutic development.

Company Name	Headquarters	Core Competencies
Agilent Technologies, Inc.	Santa Clara, California, USA	Oligonucleotide synthesis instruments, reagents, and analytical solutions
ATDBio Ltd.	Southampton, England, United Kingdom	Custom oligonucleotide synthesis and modified oligonucleotides
BioAutomation Corporation	Plano, Texas, USA	Automated DNA/RNA synthesizers and oligonucleotide synthesis equipment
Bio-Synthesis, Inc.	Lewisville, Texas, USA	Custom DNA, RNA, peptide, and oligonucleotide manufacturing
Eurofins Genomics	Ebersberg, Germany	Custom oligonucleotide synthesis, sequencing, and genomics services
Eurogentec	Seraing, Belgium	GMP oligonucleotide manufacturing and molecular biology products
GenScript Biotech Corporation	Nanjing, China	Custom oligonucleotide synthesis, gene synthesis, and molecular biology services
GeneDesign, Inc.	Osaka, Japan	Gene synthesis and custom oligonucleotide manufacturing
Integrated DNA Technologies	Coralville, Iowa, USA	Custom DNA/RNA oligonucleotides, CRISPR reagents, and GMP oligos
LGC Biosearch Technologies	Novato, California, USA	Custom oligonucleotides, qPCR probes, and nucleic acid chemistry
Merck KGaA	Darmstadt, Germany	Oligonucleotide synthesis reagents, APIs, and life science solutions
Nitto Denko Avecia	Milford, Massachusetts, USA	GMP oligonucleotide CDMO and large-scale manufacturing
Thermo Fisher Scientific Inc.	Waltham, Massachusetts, USA	Custom oligonucleotide synthesis, reagents, and molecular biology products
TriLink BioTechnologies	San Diego, California, USA	Modified oligonucleotides, mRNA, and nucleic acid manufacturing
Danaher Corporation	Washington, D.C., USA	Genomics, molecular biology, and life science technologies
Kaneka Corporation	Osaka, Japan	Oligonucleotide APIs and biopharmaceutical manufacturing
Maravai LifeSciences Holdings, Inc.	San Diego, California, USA	Nucleic acid production and bioprocessing solutions
Azenta, Inc.	Burlington, Massachusetts, USA	Genomics, sample management, and molecular biology solutions
Twist Bioscience Corporation	South San Francisco, California, USA	Synthetic DNA, oligonucleotide synthesis, and gene synthesis
Bioneer Corporation	Daejeon, South Korea	Custom oligonucleotide synthesis, molecular diagnostics, PCR reagents, and life science research solutions

Frequently Asked Questions:

1. Which region has the largest share in Global Oligonucleotide Synthesis Market?
Ans: North America region held the highest share in 2025.

2. What is the growth rate of Global Oligonucleotide Synthesis Industry?
Ans: The Market is expected to grow at a CAGR of 14.87% during forecast period 2026-2034.

3. What is scope of the Global Oligonucleotide Synthesis market report?
Ans: The report helps with the PESTEL, PORTER, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Oligonucleotide Synthesis market?
Ans: The important key players in the Market are – Gilent Technologies, Adtbio, Bioautomation, Bio-Synthesis Inc., Eurofins Genomics, Eurogentec, GE Healthcare, Genscript, Genedesign, Integrated DNA Technologies, LGC Biosearch Technologies, Merck KGaA, Nitto Denko Avecia, Thermo Fisher Scientific, Trilink Biotechnologies, Agilent Technologies, Inc, Adtbio, Sarepta Therapeutics, Inc. (US), Danaher Corporation, GeneDesign, and Inc.

5. What is the study period of this market?
Ans: The Market is studied from 2020 to 2034.

1. Oligonucleotide Synthesis Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Oligonucleotide Synthesis Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Key Players Benchmarking 2.3.1. Company Name 2.3.2. Business Segment 2.3.3. End-user Segment 2.3.4. Revenue (2025) 2.3.5. Company Locations 2.4. Leading Oligonucleotide Synthesis Market Companies, by market capitalization 2.5. Market Structure 2.5.1. Market Leaders 2.5.2. Market Followers 2.5.3. Emerging Players 2.6. Mergers and Acquisitions Details 3. Oligonucleotide Synthesis Market: Dynamics 3.1. Oligonucleotide Synthesis Market Trends by Region 3.1.1. North America Oligonucleotide Synthesis Market Trends 3.1.2. Europe Oligonucleotide Synthesis Market Trends 3.1.3. Asia Pacific Oligonucleotide Synthesis Market Trends 3.1.4. Middle East and Africa Oligonucleotide Synthesis Market Trends 3.1.5. South America Oligonucleotide Synthesis Market Trends 3.2. Oligonucleotide Synthesis Market Dynamics by Region 3.2.1. North America 3.2.1.1. North America Oligonucleotide Synthesis Market Drivers 3.2.1.2. North America Oligonucleotide Synthesis Market Restraints 3.2.1.3. North America Oligonucleotide Synthesis Market Opportunities 3.2.1.4. North America Oligonucleotide Synthesis Market Challenges 3.2.2. Europe 3.2.2.1. Europe Oligonucleotide Synthesis Market Drivers 3.2.2.2. Europe Oligonucleotide Synthesis Market Restraints 3.2.2.3. Europe Oligonucleotide Synthesis Market Opportunities 3.2.2.4. Europe Oligonucleotide Synthesis Market Challenges 3.2.3. Asia Pacific 3.2.3.1. Asia Pacific Oligonucleotide Synthesis Market Drivers 3.2.3.2. Asia Pacific Oligonucleotide Synthesis Market Restraints 3.2.3.3. Asia Pacific Oligonucleotide Synthesis Market Opportunities 3.2.3.4. Asia Pacific Oligonucleotide Synthesis Market Challenges 3.2.4. Middle East and Africa 3.2.4.1. Middle East and Africa Oligonucleotide Synthesis Market Drivers 3.2.4.2. Middle East and Africa Oligonucleotide Synthesis Market Restraints 3.2.4.3. Middle East and Africa Oligonucleotide Synthesis Market Opportunities 3.2.4.4. Middle East and Africa Oligonucleotide Synthesis Market Challenges 3.2.5. South America 3.2.5.1. South America Oligonucleotide Synthesis Market Drivers 3.2.5.2. South America Oligonucleotide Synthesis Market Restraints 3.2.5.3. South America Oligonucleotide Synthesis Market Opportunities 3.2.5.4. South America Oligonucleotide Synthesis Market Challenges 3.3. PORTER's Five Forces Analysis 3.4. PESTLE Analysis 3.5. Technology Roadmap 3.6. Regulatory Landscape by Region 3.6.1. North America 3.6.2. Europe 3.6.3. Asia Pacific 3.6.4. Middle East and Africa 3.6.5. South America 3.7. Key Opinion Leader Analysis For Oligonucleotide Synthesis Industry 3.8. Analysis of Government Schemes and Initiatives For Oligonucleotide Synthesis Industry 3.9. Oligonucleotide Synthesis Market Trade Analysis 3.10. The Global Pandemic Impact on Oligonucleotide Synthesis Market 4. Oligonucleotide Synthesis Market: Global Market Size and Forecast by Segmentation (in USD Billion) 2025-2034 4.1. Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 4.1.1. Reagents & Consumables 4.1.2. Equipment 4.1.3. Synthesized oligonucleotides 4.1.4. DNA oligonucleotides 4.1.5. RNA oligonucleotides 4.1.6. Others 4.2. Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 4.2.1. Research 4.2.2. Polymerase Chain Reaction (PCR) 4.2.3. Next Generation Sequencing 4.2.4. Therapeutics 4.2.5. Antisense Oligonucleotides 4.2.6. Nucleic Acid Aptamers 4.2.7. Diagnostics 4.2.8. Others 4.3. Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 4.3.1. Hospital 4.3.2. Pharmaceutical & Biotechnology Companies 4.3.3. Diagnostic Laboratories 4.3.4. CROs & CMOs 4.3.5. Academic Research Institutes 4.4. Oligonucleotide Synthesis Market Size and Forecast, by Region (2025-2034) 4.4.1. North America 4.4.2. Europe 4.4.3. Asia Pacific 4.4.4. Middle East and Africa 4.4.5. South America 5. North America Oligonucleotide Synthesis Market Size and Forecast by Segmentation (in USD Billion) 2025-2034 5.1. North America Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 5.1.1. Reagents & Consumables 5.1.2. Equipment 5.1.3. Synthesized oligonucleotides 5.1.4. DNA oligonucleotides 5.1.5. RNA oligonucleotides 5.1.6. Others 5.2. North America Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 5.2.1. Research 5.2.2. Polymerase Chain Reaction (PCR) 5.2.3. Next Generation Sequencing 5.2.4. Therapeutics 5.2.5. Antisense Oligonucleotides 5.2.6. Nucleic Acid Aptamers 5.2.7. Diagnostics 5.2.8. Others 5.3. North America Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 5.3.1. Hospital 5.3.2. Pharmaceutical & Biotechnology Companies 5.3.3. Diagnostic Laboratories 5.3.4. CROs & CMOs 5.3.5. Academic Research Institutes 5.4. North America Oligonucleotide Synthesis Market Size and Forecast, by Country (2025-2034) 5.4.1. United States 5.4.1.1. United States Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 5.4.1.1.1. Reagents & Consumables 5.4.1.1.2. Equipment 5.4.1.1.3. Synthesized oligonucleotides 5.4.1.1.4. DNA oligonucleotides 5.4.1.1.5. RNA oligonucleotides 5.4.1.1.6. Others 5.4.1.2. United States Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 5.4.1.2.1. Research 5.4.1.2.2. Polymerase Chain Reaction (PCR) 5.4.1.2.3. Next Generation Sequencing 5.4.1.2.4. Therapeutics 5.4.1.2.5. Antisense Oligonucleotides 5.4.1.2.6. Nucleic Acid Aptamers 5.4.1.2.7. Diagnostics 5.4.1.2.8. Others 5.4.1.3. United States Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 5.4.1.3.1. Hospital 5.4.1.3.2. Pharmaceutical & Biotechnology Companies 5.4.1.3.3. Diagnostic Laboratories 5.4.1.3.4. CROs & CMOs 5.4.1.3.5. Academic Research Institutes 5.4.2. Canada 5.4.2.1. Canada Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 5.4.2.1.1. Reagents & Consumables 5.4.2.1.2. Equipment 5.4.2.1.3. Synthesized oligonucleotides 5.4.2.1.4. DNA oligonucleotides 5.4.2.1.5. RNA oligonucleotides 5.4.2.1.6. Others 5.4.2.2. Canada Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 5.4.2.2.1. Research 5.4.2.2.2. Polymerase Chain Reaction (PCR) 5.4.2.2.3. Next Generation Sequencing 5.4.2.2.4. Therapeutics 5.4.2.2.5. Antisense Oligonucleotides 5.4.2.2.6. Nucleic Acid Aptamers 5.4.2.2.7. Diagnostics 5.4.2.2.8. Others 5.4.2.3. Canada Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 5.4.2.3.1. Hospital 5.4.2.3.2. Pharmaceutical & Biotechnology Companies 5.4.2.3.3. Diagnostic Laboratories 5.4.2.3.4. CROs & CMOs 5.4.2.3.5. Academic Research Institutes 5.4.3. Mexico 5.4.3.1. Mexico Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 5.4.3.1.1. Reagents & Consumables 5.4.3.1.2. Equipment 5.4.3.1.3. Synthesized oligonucleotides 5.4.3.1.4. DNA oligonucleotides 5.4.3.1.5. RNA oligonucleotides 5.4.3.1.6. Others 5.4.3.2. Mexico Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 5.4.3.2.1. Research 5.4.3.2.2. Polymerase Chain Reaction (PCR) 5.4.3.2.3. Next Generation Sequencing 5.4.3.2.4. Therapeutics 5.4.3.2.5. Antisense Oligonucleotides 5.4.3.2.6. Nucleic Acid Aptamers 5.4.3.2.7. Diagnostics 5.4.3.2.8. Others 5.4.3.3. Mexico Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 5.4.3.3.1. Hospital 5.4.3.3.2. Pharmaceutical & Biotechnology Companies 5.4.3.3.3. Diagnostic Laboratories 5.4.3.3.4. CROs & CMOs 5.4.3.3.5. Academic Research Institutes 6. Europe Oligonucleotide Synthesis Market Size and Forecast by Segmentation (in USD Billion) 2025-2034 6.1. Europe Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 6.2. Europe Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 6.3. Europe Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 6.4. Europe Oligonucleotide Synthesis Market Size and Forecast, by Country (2025-2034) 6.4.1. United Kingdom 6.4.1.1. United Kingdom Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 6.4.1.2. United Kingdom Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 6.4.1.3. United Kingdom Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 6.4.2. France 6.4.2.1. France Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 6.4.2.2. France Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 6.4.2.3. France Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 6.4.3. Germany 6.4.3.1. Germany Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 6.4.3.2. Germany Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 6.4.3.3. Germany Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 6.4.4. Italy 6.4.4.1. Italy Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 6.4.4.2. Italy Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 6.4.4.3. Italy Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 6.4.5. Spain 6.4.5.1. Spain Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 6.4.5.2. Spain Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 6.4.5.3. Spain Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 6.4.6. Sweden 6.4.6.1. Sweden Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 6.4.6.2. Sweden Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 6.4.6.3. Sweden Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 6.4.7. Austria 6.4.7.1. Austria Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 6.4.7.2. Austria Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 6.4.7.3. Austria Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 6.4.8. Rest of Europe 6.4.8.1. Rest of Europe Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 6.4.8.2. Rest of Europe Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 6.4.8.3. Rest of Europe Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 7. Asia Pacific Oligonucleotide Synthesis Market Size and Forecast by Segmentation (in USD Billion) 2025-2034 7.1. Asia Pacific Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 7.2. Asia Pacific Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 7.3. Asia Pacific Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 7.4. Asia Pacific Oligonucleotide Synthesis Market Size and Forecast, by Country (2025-2034) 7.4.1. China 7.4.1.1. China Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 7.4.1.2. China Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 7.4.1.3. China Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 7.4.2. S Korea 7.4.2.1. S Korea Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 7.4.2.2. S Korea Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 7.4.2.3. S Korea Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 7.4.3. Japan 7.4.3.1. Japan Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 7.4.3.2. Japan Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 7.4.3.3. Japan Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 7.4.4. India 7.4.4.1. India Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 7.4.4.2. India Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 7.4.4.3. India Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 7.4.5. Australia 7.4.5.1. Australia Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 7.4.5.2. Australia Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 7.4.5.3. Australia Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 7.4.6. Indonesia 7.4.6.1. Indonesia Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 7.4.6.2. Indonesia Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 7.4.6.3. Indonesia Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 7.4.7. Malaysia 7.4.7.1. Malaysia Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 7.4.7.2. Malaysia Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 7.4.7.3. Malaysia Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 7.4.8. Vietnam 7.4.8.1. Vietnam Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 7.4.8.2. Vietnam Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 7.4.8.3. Vietnam Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 7.4.9. Taiwan 7.4.9.1. Taiwan Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 7.4.9.2. Taiwan Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 7.4.9.3. Taiwan Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 7.4.10. Rest of Asia Pacific 7.4.10.1. Rest of Asia Pacific Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 7.4.10.2. Rest of Asia Pacific Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 7.4.10.3. Rest of Asia Pacific Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 8. Middle East and Africa Oligonucleotide Synthesis Market Size and Forecast by Segmentation (in USD Billion) 2025-2034 8.1. Middle East and Africa Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 8.2. Middle East and Africa Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 8.3. Middle East and Africa Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 8.4. Middle East and Africa Oligonucleotide Synthesis Market Size and Forecast, by Country (2025-2034) 8.4.1. South Africa 8.4.1.1. South Africa Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 8.4.1.2. South Africa Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 8.4.1.3. South Africa Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 8.4.2. GCC 8.4.2.1. GCC Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 8.4.2.2. GCC Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 8.4.2.3. GCC Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 8.4.3. Nigeria 8.4.3.1. Nigeria Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 8.4.3.2. Nigeria Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 8.4.3.3. Nigeria Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 8.4.4. Rest of ME&A 8.4.4.1. Rest of ME&A Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 8.4.4.2. Rest of ME&A Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 8.4.4.3. Rest of ME&A Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 9. South America Oligonucleotide Synthesis Market Size and Forecast by Segmentation (in USD Billion) 2025-2034 9.1. South America Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 9.2. South America Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 9.3. South America Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 9.4. South America Oligonucleotide Synthesis Market Size and Forecast, by Country (2025-2034) 9.4.1. Brazil 9.4.1.1. Brazil Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 9.4.1.2. Brazil Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 9.4.1.3. Brazil Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 9.4.2. Argentina 9.4.2.1. Argentina Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 9.4.2.2. Argentina Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 9.4.2.3. Argentina Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 9.4.3. Rest Of South America 9.4.3.1. Rest Of South America Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2025-2034) 9.4.3.2. Rest Of South America Oligonucleotide Synthesis Market Size and Forecast, by Application (2025-2034) 9.4.3.3. Rest Of South America Oligonucleotide Synthesis Market Size and Forecast, by End User (2025-2034) 10. Company Profile: Key Players 10.1. Agilent Technologies 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Inc. 10.3. ATDBio Ltd. 10.4. BioAutomation Corporation 10.5. Bio-Synthesis 10.6. Eurofins Genomics 10.7. Eurogentec 10.8. GenScript Biotech Corporation 10.9. GeneDesign 10.10. Integrated DNA Technologies 10.11. LGC Biosearch Technologies 10.12. Merck KGaA 10.13. Nitto Denko Avecia 10.14. Thermo Fisher Scientific Inc. 10.15. TriLink BioTechnologies 10.16. Danaher Corporation 10.17. Kaneka Corporation 10.18. Maravai LifeSciences Holdings 10.19. Azenta 10.20. Twist Bioscience Corporation 10.21. Bioneer Corporation 11. Key Findings 12. Industry Recommendations 13. Oligonucleotide Synthesis Market: Research Methodology 14. Terms and Glossary

Global Oligonucleotide Synthesis Market Size Oligonucleotide Production, Therapeutics & Diagnostics Demand, Biopharmaceutical Manufacturing, Research Activity, Technology Advancements, Competitive Benchmarking and Industry Forecast (2026-2034)

Global Oligonucleotide Synthesis Market Size: Oligonucleotide Production, Therapeutics & Diagnostics Demand, Biopharmaceutical Manufacturing, Research Activity, Technology Advancements, Competitive Benchmarking and Industry Forecast (2026-2034)